Trastuzumab Retreatment after Relapse on Adjuvant Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Final Results of the Retreatment after Herceptin Adjuvant Trial

2014 ◽  
Vol 26 (2) ◽  
pp. 81-89 ◽  
Author(s):  
I. Láng ◽  
R. Bell ◽  
F.Y. Feng ◽  
R.I. Lopez ◽  
J. Jassem ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Growth Factor Receptor ◽  
Adjuvant Trastuzumab ◽  
Adjuvant Trial ◽  
Trastuzumab Therapy ◽  
Epidermal Growth ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document